Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions
Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations
  • The Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Leuven Cancer Institute Leuven, Belgium
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
View Trial Details
Completed

A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia

NCT03734016

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations
  • Carti Cancer Center Little Rock, Arkansas, United States
  • David Geffen School of Medicine At UCLA Los Angeles, California, United States
  • Rocky Mountain Cancer Centers Boulder Boulder, Colorado, United States
  • Scri Florida Cancer Specialists South Fort Myers, Florida, United States
View all 115 locations
View Trial Details
Completed

A Study of Real-life Current Standards of Care in Patients With Relapsed and/or Refractory Multiple Myeloma Who Received at Least 3 Prior Lines of Therapy Including Proteasome Inhibitor (PI), Immunomodulatory Drug (IMID), and Cluster of Differentiation 38 (CD38) Monoclonal Antibody Treatment

NCT04035226

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Oncology Institute of Hope and Innovation Glendale, California, United States
  • Marin Cancer Center Greenbrae, California, United States
  • Asclepes Research Weeki Wachee, Florida, United States
  • Oncology Hematology Assoc of Central Illinois, P.C. d.b.a. Illinois CancerCare, P.C. Peoria, Illinois, United States
View all 75 locations
View Trial Details
Completed

Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice

NCT02555839

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • LKH Feldkirch, Intern E, Hämatologie Feldkirch, Austria
  • Medical University Graz Graz, Austria
  • KH der Elisabethinen Linz , 1. Interne Hämato-Onkologie Linz, Austria
  • Kepleruniversitätsklinikum GmbH, Hämatologie und Internistische Onkologie Linz, Austria
View all 13 locations
View Trial Details
Completed

A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas

NCT01877382

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Columbia University College of Physicians and Surgeons New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details

Related conditions